Press Release No. 045/KFCP-DIR/PR/VIII/21
Jakarta, August 17, 2021. PT Kalbe Farma Tbk (“Kalbe”). Pregnant women are one of the groups with the highest risk if exposed to COVID-19. The Ministry of Health has issued Circular HK.02.01/I/2007/2021 regarding COVID-19 Vaccination for Pregnant Women. For this reason, Kalbe collaborated with Kompas Gramedia, the National Population and Family Planning Agency (BKKBN), the Indonesian Obstetrics and Gynecology Association (POGI), and the Indonesian Midwives Association (IBI) to organize the opening of the Covid-19 Vaccination Center for the public that specifically targets pregnant women. The vaccination center, which starts today August 17, 2021, opened in conjunction with the celebration of the 76th anniversary of the Republic of Indonesia, the 55th anniversary of Kalbe, and the 58th anniversary of KG, took place at the BKKBN Jakarta office and SMKN 26 Jakarta. The plan is to have the Covid-19 vaccination centers with the theme Rise to Independence from Covid-19 also be held in several other cities in Indonesia, including Bandung Regency, Bantul Regency, Gresik Regency, and Pekanbaru City.
"Kalbe has the commitment to support the government in overcoming the Covid-19 pandemic, including assisting in the acceleration of the Covid-19 vaccination program for all people. We realize that this cannot be done alone, it requires collaboration with various parties," said PT Kalbe Farma Tbk President Director, Vidjongtius, "This time in conjunction with the celebration of the 76th independence of the Republic of Indonesia, Kalbe collaborated with KG, BKKBN, POGI and IBI to carry out the COVID-19 vaccination center for the general public that focuses on pregnant women. The implementation of vaccination at the BKKN Jakarta is the beginning of a series of vaccination programs that will also be carried out in several cities in Indonesia where the positive number of Covid-19 is quite high and the vaccination achievement still needs further acceleration, such as Pekanbaru, Gresik, Bandung and Bantul regencies," he said.
Vidjongtius added that Kalbe was called to carry out its mission to improve health for a better life, for a healthier and more advanced Indonesia. The vaccination program is one of the joint efforts to overcome the COVID-19 pandemic. Kalbe is currently conducting clinical trials of the COVID-19 vaccine, developing COVID-19 drugs, vitamins, and also clinical trials of stem cell therapy for Covid-19. He emphasized that this Independence Day of the Republic of Indonesia is "a momentum for all of us to be able to rise up and be free from Covid-19."
“Vaccinating pregnant women is very necessary, as well as for children. Pregnant women have the same probability of getting COVID-19 as others, but with a higher probability of dying than others, thus pregnant women are considered as a very-high risk group when exposed to COVID-19," said the Head of BKKBN Dr. (HC), dr. Hasto Wardoyo, Sp.OG (K).
Hasto also added that the stunting rate in Indonesia is currently 27.67%, and this figure could rise to 32.5% due to the COVID-19 pandemic. That is why BKKBN continues to collaborate with various parties, including launching a 1000-partner program that aims to reduce stunting rates in Indonesia to 14% by 2024.
"Hopefully today's vaccination marks a good service for pregnant women and creates a superior generation for Advanced Indonesia," he concluded.
“Today in the spirit of our 76th independence, we prove that we can be united, we collaborate and complement each other. Kalbe and BKKBN through the aspect of health and medicine, Kompas Gramedia contributes in terms of education and communication. We believe we can face this independence challenge,” said Rikard Bagun, Vice Chief Executive Officer of KG Media. "In the midst of the Covid-19 Pandemic that is yet to be over, this is a social contribution that we can make for the country, the government has made maximum efforts to provide vaccines for the community, now is the time for us to complete the vaccination program in remote areas of Indonesia, especially in areas where vaccination achievement is still not optimal in order to hasten the forming of group immunity; and this is where Kompas Gramedia collaborates with Kalbe, BKKBN and all partners in the region to take part in this humanitarian activity," he added.
While Dr. Ari Kusuma Januarto, SpOG(K), general chairman of POGI in his speech said that pregnant women are very easy to be exposed to or expose COVID-19 to others. He noted that 20% of maternal deaths were caused by pregnant women who were exposed to COVID-19, and 52% of pregnant women who were affected by COVID-19 were People Without Symptoms (OTG).
"We are grateful and support this collaboration in order to make the nation healthy, because pregnant women will give birth to a generation of hope for the nation towards an advanced Indonesia," he said again.
"The Indonesian Midwives Association also continues to strive to improve the health of pregnant women, not only healthy from COVID-19 but also reducing maternal or child mortality, and stunting. We are ready to collaborate in this vaccination activity throughout Indonesia,” added the Secretary-General of the Indonesian Midwives Association, Dr. Ade Jubaedah, SSiT, MM, MK
At the opening of the COVID-19 Vaccination Center at the BKKBN today, donations from Kalbe and the Kompas Humanitarian Fund were also handed over to the surrounding community. Donations from Kalbe are in the form of nutritional products, specific for pregnant women, such as Prenagen, Entrasol, Diabetasol, and other vitamins. In addition, through the Kompas Humanitarian Fund (DKK), 300 food packages will also be distributed, each containing rice, cooking oil, granulated sugar, wheat flour, canned sardines, cloth and medical masks, plus multivitamin products.
Kalbe at a glance
PT Kalbe Farma Tbk ("Kalbe") was established in 1966 and is one of the largest listed pharmaceutical companies in Southeast Asia. Kalbe has four main divisions that handle reliable and varied brand portfolio: prescription medicines (Cefspan, Hemapo, Broadced, etc.); health product division that handles over-the-counter medication (Promag, Mixagrip, Komix, Woods, Fatigon, etc.); as well as energy and ready-to-consume drinks (Extra Joss, Hydro Coco); nutrition division (ChilKid, Prenagen, Diabetasol, etc.); and distribution division. Kalbe currently has approximately 40 subsidiaries and 12 production facilities with international standard, and employs approximately 17,000 employees dispersed across more than 76 branches throughout Indonesia. From 1991, Kalbe is listed on the Indonesia Stock Exchange (IDX: KLBF).